A new study presented at the European Respiratory Society Conference in Vienna suggests that popular epilepsy drug Sulthiame may reduce major Obstructive Sleep Apnea (OSA) symptoms. According to ...

European epilepsy drug sulthiame could be an effective treatment for sleep apnea, a new study suggests.

Sulthiame, an epilepsy drug sold under the brand name Ospolot in Europe, appeared to reduce symptoms of obstructive sleep apnea (OSA) in a late-breaking clinical trial presented at the European ...

Sulthiame is currently used to treat childhood epilepsy. The post Epilepsy drug shows signs it can cure obstructive sleep apnea appeared first on Talker.

The magnitude was much greater in children than adults, and central sleep apnea was tied to greater risk than obstructive sleep apnea.

Finally, there are now strong data to show that in people with sleep apnea and obesity, treatment with a GLP-1 agent can reduce sleep apnea.Severe untreated sleep apnea is a cause for heart failure.

Also, it is known that if taken for weight loss, the drug will likely be taken for life. Malhotra said research is still out on whether the same goes for treating sleep apnea.

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

Patients taking sulthiame - currently used for childhood epilepsy - in a clinical trial experienced a reduction in their symptoms of obstructive sleep apnea (OSA), say scientists.